Physician profile
James Temple
NPI 1063588002
$2,491.30
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $581 · 2021: $1,128 · 2022: $134 · 2023: $12.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $660.44 | 2019-2021 | |
| Novo Nordisk INC | $371.29 | 2019-2021 | |
| Amgen INC. | $233.64 | 2019-2022 | |
| Glaxosmithkline, LLC. | $151.17 | 2020-2021 | |
| Abbvie INC. | $150.66 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $146.52 | 2019-2022 | |
| Pfizer INC. | $103.02 | 2019-2022 | |
| Allergan, INC. | $101.09 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $84.07 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $78.98 | 2020-2021 | |
| Lilly USA, LLC | $70.67 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $50.77 | 2020-2021 | |
| Eisai INC. | $45.67 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $37.57 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.92 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $29.58 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.50 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.34 | 2019 | |
| Csl Behring | $23.92 | 2019 | |
| Mylan Specialty L.P. | $18.16 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.47 | 2021 | |
| Amarin Pharma, INC. | $14.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Temple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.